Xcellerant Ventures

About The Fund

Xcellerant Ventures is a venture capital firm that specializes in seeding and developing growth within the healthcare sector, particularly focusing on BioTech, HealthTech and Fitness, Medical Devices and Hospital Services, Healthcare and Wellness, and LegalTech industries. With a strong dedication to fostering the future of healthcare innovation, they aim to invest in companies that can transform the healthcare space by enhancing quality, efficiency, access, and delivery of services while concurrently reducing costs. Their people-first philosophy underlines a commitment to empowering entrepreneurs who are poised to make significant and positive changes in the world. Xcellerant Ventures' investment strategy is sharply focused on early-stage funding, targeting healthtech and medtech companies. They look for dynamic founders who are humble, receptive to guidance, lead by example, and have a determined vision for global betterment. An emphasis on rapid exits is apparent, as they favor companies that are already generating revenue, have overcome regulatory barriers, and are on a swift track to financial growth. The healthcare sector, with its ripe potential for investment due to the interplay of transformative technologies and the pressing need for enhanced service delivery, is their playground for investment. Emerging technologies that address real-world issues while amplifying healthcare quality, accessibility, efficiency, and affordability are particularly attractive to Xcellerant Ventures. The founding team consists of John Shufeldt, Douglas Sylvester, and Chris Yoo, who bring an extensive background of over 70 years combined in medical technologies, law, and entrepreneurship. This team is not only founder-centric in its approach, offering personalized advice and support but also boasts a unique General Partner (GP) experience that aligns with the healthcare sector’s demands. Their perspective is that first-time fund managers often outperform established funds with the right GPs at the helm. Xcellerant Ventures positions itself to accelerate healthcare innovation by strategically positioning its investments towards companies with the potential for hyper-growth within the healthtech and medtech space. With an investment range from $100,000 to $5,000,000 and a sweet spot of $1,500,000, they target stages including Seed, Series A, and Series B rounds.